Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial | 最新消息 - 中國醫藥大學附設醫院

最新消息

News & Message

:::

Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial

最新消息

2/5/2025

Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial

Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial

作者群：(Paul Glue)*、(Colleen Loo)、(Johnson Fam)、藍先元(Hsien-Yuan Lane)、(Allan H. Young)、(Peter Surman)、(BEDROC study investigators)

期刊：NATURE MEDICINE

出版年月：2024

連結：https://pubmed.ncbi.nlm.nih.gov/38914860/

回上頁

相關文章

Diagnosing Alzheimer's Disease Specifically and Sensitively With pLG72 and Cystine/Glutamate Antiporter SLC7A11 AS Blood Biomarkers

Diagnosing Alzheimer's Disease Specifically and Sensitively With pLG72 and Cystine/Glutamate Antiporter SLC7A11 AS Blood Biomarkers

Targeting D-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research

Targeting D-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research

Effect of Sodium Benzoate on Cognitive Function Among Patients With Behavioral and Psychological Symptoms of Dementia: Secondary Analysis of a Randomized Clinical Trial

Effect of Sodium Benzoate on Cognitive Function Among Patients With Behavioral and Psychological Symptoms of Dementia: Secondary Analysis of a Randomized Clinical Trial

側邊開關圖示

中國醫點通